TNF Pharmaceuticals Announces New Board and Shareholder Votes

Don't Miss our Black Friday Offers:

TNF Pharmaceuticals ( (TNFA) ) just unveiled an update.

At the recent Annual Meeting, TNF Pharmaceuticals, Inc. saw the election of seven directors to its board, approval of an amendment to its 2021 Equity Incentive Plan increasing available shares for awards, and the ratification of Stephano Slack LLC as its independent auditor for 2024. Additionally, a proposal to potentially adjourn the meeting for further proxy votes was approved, reflecting robust shareholder participation and engagement in the company’s governance.

See more data about TNFA stock on TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.